These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17366447)

  • 1. Varicella vaccination in adults: is it cost-effective?
    Lee GM
    Clin Infect Dis; 2007 Apr; 44(8):1049-50. PubMed ID: 17366447
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of varicella vaccination of healthcare workers.
    Chodick G; Ashkenazi S; Livni G; Lerman Y
    Vaccine; 2005 Oct; 23(43):5064-72. PubMed ID: 16046036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
    Bonanni P; Boccalini S; Bechini A; Banz K
    Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Gamboa-Garay O; Castañeda-Orjuela C; Velandia-González M; Alvis-Guzmán N
    Vaccine; 2013 Jan; 31(2):402-9. PubMed ID: 23174195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to prevent varicella among newly arrived adult immigrants and refugees: a cost-effectiveness analysis.
    Merrett P; Schwartzman K; Rivest P; Greenaway C
    Clin Infect Dis; 2007 Apr; 44(8):1040-8. PubMed ID: 17366446
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and economic considerations of vaccination against varicella.
    Strassels SA; Sullivan SD
    Pharmacotherapy; 1997; 17(1):133-9. PubMed ID: 9017774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of varicella vaccination programs: an update of the literature.
    Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
    Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella vaccination strategies.
    Meurer LN; Slawson JG
    J Fam Pract; 1998 Nov; 47(5):331-2. PubMed ID: 9834759
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
    Smith KJ; Roberts MS
    Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].
    Knuf M; Neiss A; Wutzler P
    Klin Padiatr; 2006; 218(4):203-12. PubMed ID: 16819701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An economic analysis of the universal varicella vaccination program in the United States.
    Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
    Tseng HF; Tan HF; Chang CK
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1450-8. PubMed ID: 16610647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of varicella contacts in pregnancy: VZIG or vaccination?
    Troughton JA; Crealey G; Crawford V; Coyle PV
    J Clin Virol; 2009 Dec; 46(4):345-8. PubMed ID: 19828369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella vaccine, cost-effectiveness analyses, and vaccination policy.
    Davis MM
    JAMA; 2005 Aug; 294(7):845-6. PubMed ID: 16106012
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic evaluation of Varicella vaccination: results of a systematic review.
    Unim B; Saulle R; Boccalini S; Taddei C; Ceccherini V; Boccia A; Bonanni P; La Torre G
    Hum Vaccin Immunother; 2013 Sep; 9(9):1932-42. PubMed ID: 23823940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case against universal varicella vaccination.
    Goldman GS
    Int J Toxicol; 2006; 25(5):313-7. PubMed ID: 16940003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination.
    Hall J; Kenny P; King M; Louviere J; Viney R; Yeoh A
    Health Econ; 2002 Jul; 11(5):457-65. PubMed ID: 12112494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong.
    Chui KS; Wu HL; You JH
    Scand J Infect Dis; 2014 Jan; 46(1):27-33. PubMed ID: 24228821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.